Have you recently had or are planning to have an ACL reconstruction? You may be eligible to participate in an observational study! We aim to better understand how ACL-related fears can predict surgical outcomes at 9-months post-operatively.

We are looking for ways to help people with certain types of cancer that spread and become very serious. SolveTx has created a new treatment to target these cancers. If you join, you will have some check-ups before and after the treatment and get the study treatment. We'll make sure to keep an eye on how you're doing for about 3 years after your treatment finishes.

This study is assessing the usefulness of a text message based intervention to reduce excessive alcohol use among young adults ages 18-25. Participants will attend a Baseline Session over Zoom where they will complete a 25-minute survey and learn more about study procedures. Then, participants will receive daily prompts to their personal cellphone Wednesday-Sunday for 2 weeks. After the 2-week trial, participants will attend 1 focus group over Zoom to share their experiences in the study.

The purpose of this study is to test if BGB-16673 and pirtobrutinib are safe and test how well BGB-16673 compares to pirtobrutinib in participants with previously treated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

We are looking for Latino youth (ages 13-19) and one of their parents to take part in a research study.

Are you a media expert, policymaker or business leader concerned about the impact of EU regulations on media? You may be able to participate in a research study about how to prepare future media professionals for changes in the regulatory landscape.

Do you have chronic spontaneous urticaria? Are you having symptoms despite using antihistamines? If so, you may be able to participate in a research study to find out how effective Remibrutinib is in patients with chronic spontaneous urticaria.

If you have Leukemia and are looking for an alternative treatment, you may be eligible to participate in a research study testing a new drug called AUTX-007.

The iTREAT study will compare different guideline approved ways of treating adults and teens with asthma to see if they reduce the need for emergency care or hospital visits. Some participants will use their controller inhaler with or instead of a reliever inhaler. Others will take an antibiotic pill and some participants will use both. Participation lasts for 16 months. Every other month you will answer questions about your asthma through an online or telephone survey.

Are you 18 years of age and younger than 75 years old? Do you or do you know someone with Peripheral T-cell Lymphoma? Would you be interested in using your own stem cells versus only using chemotherapy infusions? If you have large cell lymphoma (ALCL) ALK-negative, this study may interest you.